Please Wait
Applying Filters...
menu
    • menu
    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Synnat Pharma is one of the leading active pharmaceutical ingredients and intermediates manufacturers.

    Virtual Booth

    Contact Supplier

    Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Albutrepenonacog Alfa

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic
    IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic

    03 Jul 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/idelvion-becomes-first-and-only-factor-ix-therapy-with-21-day-prophylactic-dosing-301087867.html

    PRNEWSWIRE
    03 Jul 2020
    Share Share
    IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic
    IDELVION® Becomes First and Only Factor IX Therapy with 21-Day Prophylactic

    02 Jul 2020

    // PRNEWSWIRE

    http://prnewswire.com/news-releases/idelvion-becomes-first-and-only-factor-ix-therapy-with-21-day-prophylactic-dosing-301087867.html#:~:text=IDELVION%C2%AE%2C%20the%20most%20prescribed,possibility%20of%2021-day%20dosing.&text=Haemophilia%20B%20is%20a%20congenital,all%20affected%20patients%20are%20male.

    PRNEWSWIRE
    02 Jul 2020
    Share Share
    Hemophilia B has new treatment
    Hemophilia B has new treatment

    11 Oct 2018

    // ANVISA

    http://portal.anvisa.gov.br/noticias?p_p_id=101_INSTANCE_FXrpx9qY7FbU&p_p_col_id=column-2&p_p_col_pos=1&p_p_col_count=2&_101_INSTANCE_FXrpx9qY7FbU_groupId=219201&_101_INSTANCE_FXrpx9qY7FbU_urlTitle=hemofilia-b-tem-novo-tratamento&_101_INSTANCE_FXrpx9qY7FbU_struts_action=%2Fasset_publisher%2Fview_content&_101_INSTANCE_FXrpx9qY7FbU_assetEntryId=5002096&_101_INSTANCE_FXrpx9qY7FbU_type=content

    ANVISA
    11 Oct 2018
    Share Share